The effect of St 155 on the active reflex vasodilatation induced by adrenaline, noradrenaline and veratrine
- 1 October 1969
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 8 (1) , 39-46
- https://doi.org/10.1016/0014-2999(69)90127-7
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Studies of the new hypotensive drug ST 155European Journal of Pharmacology, 1968
- Mechanisms of the pressor and depressor actions of St 155 (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, catapres®)European Journal of Pharmacology, 1968
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155)European Journal of Pharmacology, 1968
- OBSERVATIONS ON THE HYPOTENSIVE ACTION OF “CATAPRES” (ST 155) IN MANThe Medical Journal of Australia, 1968
- Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HClEuropean Journal of Pharmacology, 1967
- Acute hypotensive action of 2-(2,6-dichlorophenylamino)- 2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral arteryEuropean Journal of Pharmacology, 1967
- Pressor Effects of Adrenaline, Noradrenaline and Reflex Vasoconstriction Sensitised by Low Concentrations of Ganglion Blocking DrugsJournal of Pharmacy and Pharmacology, 1963
- Mechanisms by which ganglioplegics and atropine enhance cardiovascular responsivenessAmerican Journal of Physiology-Legacy Content, 1963
- Active reflex dilatation in the innervated perfused hind leg of the dogAmerican Journal of Physiology-Legacy Content, 1961
- Pharmacological evidence for active reflex dilatationAmerican Journal of Physiology-Legacy Content, 1961